The changing demographic pattern of multiple sclerosis epidemiology by Koch-Henriksen, Nils, MD, Sørensen, Per Soelberg, MD

Get full text

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-contr... by Sorensen, Per Soelberg, MD, Mellgren, Svein Ivar, MD, Svenningsson, Anders, MD, Elovaara, Irina, MD, Frederiksen, Jette Lautrup, MD, Beiske, Antonie Giaever, MD, Myhr, Kjell-Morten, MD, Søgaard, Lise Vejby, PhD, Olsen, Inge Christoffer, PhD, Sandberg-Wollheim, Magnhild, MD

Get full text

Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb s... by Giovannoni, Gavin, MD, Barbarash, Olga, MD, Casset-Semanaz, Florence, PhD, Jaber, Amer, PhD, King, John, MD, Metz, Luanne, MD, Pardo, Gabriel, MD, Simsarian, James, MD, Sørensen, Per Soelberg, MD, Stubinski, Bettina, MD

Get full text

Evolving concepts in the treatment of relapsing multiple sclerosis by Comi, Giancarlo, Prof, Radaelli, Marta, MD, Soelberg Sørensen, Per, Prof

Get full text

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysi... by Giovannoni, Gavin, Prof, Cook, Stuart, Prof, Rammohan, Kottil, Prof, Rieckmann, Peter, MD, Sørensen, Per Soelberg, Prof, Vermersch, Patrick, Prof, Hamlett, Anthony, PhD, Viglietta, Vissia, MD, Greenberg, Steven, MD

Get full text

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis by Polman, Chris H, Prof, Bertolotto, Antonio, MD, Deisenhammer, Florian, Prof, Giovannoni, Gavin, Prof, Hartung, Hans-Peter, Prof, Hemmer, Bernhard, Prof, Killestein, Joep, MD, McFarland, Henry F, MD, Oger, Joel, Prof, Pachner, Andrew R, Prof, Petkau, John, Prof, Reder, Anthony T, MD, Reingold, Stephen C, PhD, Schellekens, Huub, Prof, Sørensen, Per Soelberg, Prof

Get full text

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled,... by Ravnborg, Mads, MD, Sørensen, Per Soelberg, Prof, Andersson, Magnus, MD, Celius, Elisabeth G, MD, Jongen, Peter J, MD, Elovaara, Irina, MD, Bartholomé, Emmanuel, MD, Constantinescu, Cris S, MD, Beer, Karsten, MD, Garde, Ellen, MD, Sperling, Bjørn, MD

Get full text

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial by Sorensen, Per Soelberg, Prof, Lycke, Jan, MD, Erälinna, Juha-Pekka, MD, Edland, Astrid, MD, Wu, Xingchen, MD, Frederiksen, Jette Lautrup, MD, Oturai, Annette, MD, Malmeström, Clas, MD, Stenager, Egon, MD, Sellebjerg, Finn, MD, Sondergaard, Helle Bach, MS

Get full text

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring by Kappos, Ludwig, Prof, Bates, David, Prof, Edan, Gilles, Prof, Eraksoy, Mefkûre, MD, Garcia-Merino, Antonio, MD, Grigoriadis, Nikolaos, MD, Hartung, Hans-Peter, Prof, Havrdová, Eva, MD, Hillert, Jan, MD, Hohlfeld, Reinhard, Prof, Kremenchutzky, Marcelo, MD, Lyon-Caen, Olivier, Prof, Miller, Ariel, MD, Pozzilli, Carlo, Prof, Ravnborg, Mads, MD, Saida, Takahiko, MD, Sindic, Christian, Prof, Vass, Karl, MD, Clifford, David B, Prof, Hauser, Stephen, Prof, Major, Eugene O, PhD, O'Connor, Paul W, Prof, Weiner, Howard L, Prof, Clanet, Michel, Prof, Gold, Ralf, Prof, Hirsch, Hans H, Prof, Radü, Ernst-Wilhelm, Prof, Sørensen, Per Soelberg, Prof, King, John, MD

Get full text